What is the address of CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE?

The registered office of CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE is located at Voie de l'Ardenne 75, 4053 Chaudfontaine.

Is CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 July 1993; 5 annual accounts filed, latest fiscal year 2025.

CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE

Q: Is CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE still active?

Yes. According to the CBE (18 September 2026) CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE is active, legal situation “Normale toestand”, started on 5 July 1993.

Q: Is CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE registered on Peppol?

Yes, CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE is registered on the Peppol network with ID 0208:0450392774.

Q: What is the enterprise number of CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE?

The enterprise number of CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE is BE0450392774.

Q: When was CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE founded?

CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE was founded on 5 July 1993.

Q: What is the revenue of CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE?

In its most recent annual accounts (2025), CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE reported revenue of € 13,648.

Dossier CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE, printed on 18 September 2026 from databakkes.be/en/0450392774/centre-de-dermatologie-a-but-scientifique-et-therapeutique. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE from Chaudfontaine, company number BE0450392774, closed financial year 2025 with a result of € -5,191 after tax. For that financial year CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE recorded revenue of € 13,648 and equity of € 260,679. Compared with financial year 2024, the result moved from € -10,373 to € -5,191. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 5, 2026.

What it is worth Healthy

€ 260,679

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -5,191

▲ 50 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 12,864

▼ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 242,039.

People and assets in 2025

Vehicles and equipment

€ 145,325

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 213

▼ 66% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 10,320 Revenue 2022: € 10,320 First fiscal year in the series	€ 12,420 Revenue 2023: € 12,420 ▲ 20% vs 2022 (€ 10,320) Favourable step	€ 11,100 Revenue 2024: € 11,100 ▼ 11% vs 2023 (€ 12,420) Unfavourable step	€ 13,648 Revenue 2025: € 13,648 ▲ 23% vs 2024 (€ 11,100) Favourable step	▲ 23%
Gross margin	€ -6,465 Gross margin 2022: € -6,465 First fiscal year in the series	€ -13,318 Gross margin 2023: € -13,318 ▼ € 6,853 vs 2022 (€ -6,465) Unfavourable step	€ -8,440 Gross margin 2024: € -8,440 ▲ € 4,878 vs 2023 (€ -13,318) Favourable step	€ 103 Gross margin 2025: € 103 ▲ € 8,543 vs 2024 (€ -8,440) Favourable step	▲ € 8,543
Profit after taxes	€ -8,527 Profit after taxes 2022: € -8,527 First fiscal year in the series	€ 46,243 Profit after taxes 2023: € 46,243 ▲ € 54,770 vs 2022 (€ -8,527) Favourable step	€ -10,373 Profit after taxes 2024: € -10,373 ▼ € 56,616 vs 2023 (€ 46,243) Unfavourable step	€ -5,191 Profit after taxes 2025: € -5,191 ▲ € 5,181 vs 2024 (€ -10,373) Favourable step	▲ € 5,181
Equity	€ 230,000 Equity 2022: € 230,000 First fiscal year in the series	€ 276,243 Equity 2023: € 276,243 ▲ 20% vs 2022 (€ 230,000) Favourable step	€ 265,871 Equity 2024: € 265,871 ▼ 4% vs 2023 (€ 276,243) Unfavourable step	€ 260,679 Equity 2025: € 260,679 ▼ 2% vs 2024 (€ 265,871) Unfavourable step	▼ 2%
Total debts	€ 77,930 Total debts 2022: € 77,930 First fiscal year in the series	€ 25,757 Total debts 2023: € 25,757 ▼ 67% vs 2022 (€ 77,930) Favourable step	€ 31,971 Total debts 2024: € 31,971 ▲ 24% vs 2023 (€ 25,757) Unfavourable step	€ 39,086 Total debts 2025: € 39,086 ▲ 22% vs 2024 (€ 31,971) Unfavourable step	▲ 22%
Cash	€ 14,556 Cash 2022: € 14,556 First fiscal year in the series	€ 23,627 Cash 2023: € 23,627 ▲ 62% vs 2022 (€ 14,556) Favourable step	€ 19,734 Cash 2024: € 19,734 ▼ 16% vs 2023 (€ 23,627) Unfavourable step	€ 12,864 Cash 2025: € 12,864 ▼ 35% vs 2024 (€ 19,734) Unfavourable step	▼ 35%
Land & buildings	€ 97,179 Land & buildings 2022: € 97,179 First fiscal year in the series	€ 97,179 Land & buildings 2023: € 97,179 Unchanged (€ 97,179) Unchanged	€ 97,179 Land & buildings 2024: € 97,179 Unchanged (€ 97,179) Unchanged	€ 93,709 Land & buildings 2025: € 93,709 ▼ 4% vs 2024 (€ 97,179) Unchanged	▼ 4%
Retained profit	€ 211,360 Retained profit 2022: € 211,360 First fiscal year in the series	€ 257,603 Retained profit 2023: € 257,603 ▲ 22% vs 2022 (€ 211,360) Favourable step	€ 247,231 Retained profit 2024: € 247,231 ▼ 4% vs 2023 (€ 257,603) Unfavourable step	€ 242,039 Retained profit 2025: € 242,039 ▼ 2% vs 2024 (€ 247,231) Unfavourable step	▼ 2%
Bank debt	€ 18,704 Bank debt 2022: € 18,704 First fiscal year in the series	€ 4,918 Bank debt 2023: € 4,918 ▼ 74% vs 2022 (€ 18,704) Favourable step	€ 215 Bank debt 2024: € 215 ▼ 96% vs 2023 (€ 4,918) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 215) Favourable step	▼ 100%
Balance sheet total	€ 307,930 Balance sheet total 2022: € 307,930 First fiscal year in the series	€ 302,001 Balance sheet total 2023: € 302,001 ▼ 2% vs 2022 (€ 307,930) Unchanged	€ 297,842 Balance sheet total 2024: € 297,842 ▼ 1% vs 2023 (€ 302,001) Unchanged	€ 299,765 Balance sheet total 2025: € 299,765 ▲ 1% vs 2024 (€ 297,842) Unchanged	▲ 1%

Key figures of CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE?

What happened at CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 5, 2026 New annual accounts for financial year 2025: loss of € 5,191. filed late Source: NBB ↗
Jul 5, 1993 Start of the company according to the CBE. KBO

In short

From € 8,527 loss in 2022 to € 5,191 loss in 2025.

Paid € 78 in corporate taxes since 2022.

Best year ever: 2023, with € 46,243 profit.

Original PDFs at the National Bank ↗

A new publication or filing at CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE? We notify you, reason included.

Follow CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Voie de l'Ardenne 75

4053 Chaudfontaine

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

CODERMA

€ 299,237 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0450.392.774
VAT number: BE 0450.392.774
Registered office: Voie de l'Ardenne 75, 4053 Chaudfontaine
Names & denominations: CENTRE DE DERMATOLOGIE A BUT SCIENTIFIQUE ET THERAPEUTIQUE · C.D.S.T.
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 July 1993
Peppol: Active · Active since 30 Jan 2025

View on CBE Public ↗ Annual accounts (NBB) ↗